180 likes | 339 Views
First Response: NSCLC Highlights From Chicago. RTOG 0617 Overall Survival Results. ALK Rearrangement Positive Advanced NSCLC. MPDL3280A Phase Ia: Response by PD-L1 IHC Status. GALAXY-1 Overall Survival: Adenocarcinoma. LUME Lung 1: Overall Survival Adenocarcinoma.
E N D